Clinical Trial Update: Effect of Intralymphatic Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of intralymphatic immunotherapy completed; results posted in 2021 for allergy/immune tolerance conditions with injection site discomfort …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergy
• Immune Tolerance

Snippet

Sponsor: University of Aarhus | Conditions: Allergy, Immune Tolerance | Phase 2 | Status: COMPLETED | Results posted: 2021-03-18